DataVXJournal of Nanoparticle ResearchPaper
journal article·2024-06

Nanodispersions for drug delivery applications: a special focus toward cancer therapeutics

Vaidevi Sethuraman, Abilesh Ramesh, Kumar Janakiraman, Nagaraj Balakrishnan

Journal of Nanoparticle Research· Volume 26· Issue 6
Publisher page
Bibliographic record

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

Nanomaterials

OpenAlex topics: Nanoparticle-Based Drug Delivery · RNA Interference and Gene Delivery · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Donadon LGF, Salata GC, Gonçalves TP et al (2023) Monoolein-based nanodispersions for cutaneous co-delivery of methylene blue and metformin: thermal and structural characterization and effects on the cutaneous barrier, skin penetration and cytotoxicity. Int J Pharm 633:122612. https://doi.org/10.1016/j.ijpharm.2023.12261210.1016/j.ijpharm.2023.122612 ↗
2. Lalu L, Tambe V, Pradhan D et al (2017) Novel nanosystems for the treatment of ocular inflammation: current paradigms and future research directions. J Control Release 268:19–39. https://doi.org/10.1016/j.jconrel.2017.07.03510.1016/j.jconrel.2017.07.035 ↗
3. Abid N, Khan AM, Shujait S et al (2021) Adv Colloid Interface Sci 300. https://doi.org/10.1016/j.cis.2021.10259710.1016/j.cis.2021.102597 ↗
4. Garrigue P, Delville MH, Labrugère C et al (2004) Top−down approach for the preparation of colloidal carbon nanoparticles. Chem Mater 16(16):2984–2986. https://doi.org/10.1021/cm049685i10.1021/cm049685i ↗
5. Jamkhande PG, Ghule NW, Bamer AH, Kalaskar MG (2019) Metal nanoparticles synthesis: an overview on methods of preparation, advantages and disadvantages, and applications. J Drug Deliv Sci Technol 53. https://doi.org/10.1016/j.jddst.2019.10117410.1016/j.jddst.2019.101174 ↗
6. Almajidi Yasir Q, Maraie NK, Raauf AMR (2022) Utilization of solid in oil nanodispersion to prepare a topical vemurafenib as potential delivery system for skin melanoma. Appl Nanosci. 2022:1–12. https://doi.org/10.1007/s13204-021-02158-y10.1007/s13204-021-02158-y ↗
7. Calis B, Yilmaz M (2021) Fabrication of gold nanostructure decorated polystyrene hybrid nanosystems via poly(L-DOPA) and their applications in surface-enhanced Raman Spectroscopy (SERS), and catalytic activity. Colloids Surf A Physicochem Eng Asp 622. https://doi.org/10.1016/j.colsurfa.2021.12665410.1016/j.colsurfa.2021.126654 ↗
8. MPharm GN, Jose J (2018) J Cosmet Dermatol 17(6):1073–1083. https://doi.org/10.1111/jocd.1247010.1111/jocd.12470 ↗
9. Dos Santos KM, Barbosa RM, Vargas FGA et al (2018) Development of solid dispersions of β-lapachone in PEG and PVP by solvent evaporation method. Drug Dev Ind Pharm 44(5):750–756. https://doi.org/10.1080/03639045.2017.141194210.1080/03639045.2017.1411942 ↗
10. Shetty N, Cipolla D, Park H, Zhou QT (2020) Physical stability of dry powder inhaler formulations. Expert Opin Drug Deliv 17(1):77–96. https://doi.org/10.1080/17425247.2020.170264310.1080/17425247.2020.1702643 ↗
11. Kumar S (2018) Pharmaceutical Cocrystals: An Overview. Indian J Pharm Sci 79:858–871. https://doi.org/10.1016/j.ijpharm.2011.07.03710.1016/j.ijpharm.2011.07.037 ↗
12. Kumar AR (2019) Overview of Nano-suspensions technology. World J Pharm Sci 8:491–500. https://doi.org/10.20959/wjpps201912-1516110.20959/wjpps201912-15161 ↗
13. Chakraborty PMSI, Rakshit AK (2022) Role of surface-active materials (amphiphiles and surfactants) in the formation of nanocolloidal dispersions, and their applications. J Surfactants Deterg 6:703–727. https://doi.org/10.1002/jsde.1261210.1002/jsde.12612 ↗
14. Jafari SM, Sedaghat Doost A, Nikbakht Nasrabadi M, Boostani S, Van der Meeren P (2020) Phytoparticles for the stabilization of Pickering emulsions in the formulation of novel food colloidal dispersions. Trends Food Sci Technol 98:117–128. https://doi.org/10.1016/j.tifs.2020.02.00810.1016/j.tifs.2020.02.008 ↗
15. Lakshmi P, Kumar GA (2010) Nanosuspension technology: A review. Int J Pharm Sci 2:35–40
16. Klochkov SG, Neganova ME, Nikolenko VN et al (2021) Implications of nanotechnology for the treatment of cancer: recent advances. Semin Cancer Biol 69:190–199. https://doi.org/10.1016/j.semcancer.2019.08.02810.1016/j.semcancer.2019.08.028 ↗
17. Seigel GM, Campbell LM, Narayan M, Gonzalez-Fernandez F (2005) Cancer stem cell characteristics in retinoblastoma. Mol Vis 11:729–737
18. Jin C, Wang K, Oppong-Gyebi A, Hu J (2020) Application of nanotechnology in cancer diagnosis and therapy – a mini-review. Int J Med Sci 17(18):2964–2973. https://doi.org/10.7150/ijms.4980110.7150/ijms.49801 ↗
19. Sahu T, Ratre YK, Chauhan S, Bhaskar LVKS, Nair MP, Verma HK (2021) Nanotechnology based drug delivery system: current strategies and emerging therapeutic potential for medical science. J Drug Deliv Sci Technol 63. https://doi.org/10.1016/j.jddst.2021.102487.10.1016/j.jddst.2021.102487 ↗
20. Kirtane AR, Verma M, Karandikar P, Furin J, Langer R, Traverso G (2021) Nanotechnology approaches for global infectious diseases. Nat Nanotechnol 16(4):369–384. https://doi.org/10.1038/s41565-021-00866-810.1038/s41565-021-00866-8 ↗
21. Medina-Cruz D, Mostafavi E, Vernet-Crua A et al (2020) Green nanotechnology-based drug delivery systems for osteogenic disorders. Expert Opin Drug Deliv 17(3):341–356. https://doi.org/10.1080/17425247.2020.172744110.1080/17425247.2020.1727441 ↗
22. Kang YF, Sun C, Zhuang Z et al (2021) Rapid development of SARS-CoV-2 spike protein receptor-binding domain self-assembled nanoparticle vaccine candidates. ACS Nano 15(2):2738–2752. https://doi.org/10.1021/acsnano.0c0837910.1021/acsnano.0c08379 ↗
23. MacFarlane LR, Shaikh H, Garcia-Hernandez JD, Vespa M, Fukui T, Manners I (2021) Functional nanoparticles through π-conjugated polymer self-assembly. Nat Rev Mater 6(1):7–26. https://doi.org/10.1038/s41578-020-00233-410.1038/s41578-020-00233-4 ↗
24. Deng K, Luo Z, Tan L, Quan Z (2020) Self-assembly of anisotropic nanoparticles into functional superstructures. Chem Soc Rev 49:6002–6038. https://doi.org/10.1039/D0CS00541J10.1039/D0CS00541J ↗
25. Sun M, Su X, Ding B et al (2012) Advances in nanotechnology-based delivery systems for curcumin. Nanomedicine (Lond) 7(7):1085–1100. https://doi.org/10.2217/nnm.12.8010.2217/nnm.12.80 ↗
26. Oroojalian F, Charbgoo F, Hashemi M et al (2020) Recent advances in nanotechnology-based drug delivery systems for the kidney. J Control Release 321:442–462. https://doi.org/10.1016/j.jconrel.2020.02.02710.1016/j.jconrel.2020.02.027 ↗
27. Augustine R, Al Mamun AA, Hasan A et al (2021) Imaging cancer cells with nanostructures: prospects of nanotechnology driven non-invasive cancer diagnosis. Adv Colloid Interface Sci 294:102457. https://doi.org/10.1016/j.cis.2021.10245710.1016/j.cis.2021.102457 ↗
28. Yang Z, Ma Y, Zhao H, Yuan Y, Kim BYS (2020) Nanotechnology platforms for cancer immunotherapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol 12(2):e1590. https://doi.org/10.1002/wnan.159010.1002/wnan.1590 ↗
29. Kusyak AP, Petranovska AL, Turanska SP et al (2022) Him. Fiz Tehnol 13. https://doi.org/10.15407/hftp13.04.42510.15407/hftp13.04.425 ↗
30. Elsayed I, El-Dahmy RM, El-Emam SZ, Elshafeey AH, El Gawad NAA, El-Gazayerly ON (2020) Response surface optimization of biocompatible elastic nanovesicles loaded with rosuvastatin calcium: enhanced bioavailability and anticancer efficacy. Drug Deliv Transl Res 10(5):1459–1475. https://doi.org/10.1007/s13346-020-00761-010.1007/s13346-020-00761-0 ↗
31. Lee YT, Tan YJ, Oon CE (2018) Molecular targeted therapy: treating cancer with specificity. Eur J Pharmacol 834:188–196. https://doi.org/10.1016/j.ejphar.2018.07.03410.1016/j.ejphar.2018.07.034 ↗
32. Xie YH, Chen YX, Fang JY (2020) Comprehensive review of targeted therapy for colorectal cancer. Signal Transduct Target Ther 5(1):22. https://doi.org/10.1038/s41392-020-0116-z10.1038/s41392-020-0116-z ↗
33. Lyons TG (2019) Targeted therapies for triple-negative breast cancer. Curr Treat Options Oncol 20(11):82. https://doi.org/10.1007/s11864-019-0682-x10.1007/s11864-019-0682-x ↗
34. Yilmaz B, Bjorgaard J, Lin Z, Köse ME (2015) Phthalimide containing donor-acceptor polymers for effective dispersion of single-walled carbon nanotubes. Org Commun 8:78–89
35. Mishra V, Bansal KK, Verma A et al (2018) Solid lipid nanoparticles: emerging colloidal nano drug delivery systems. Pharmaceutics 10(4):191. https://doi.org/10.3390/pharmaceutics1004019110.3390/pharmaceutics10040191 ↗
36. Fam SY, Chee CF, Yong CY, Ho KL, Mariatulqabtiah AR, Tan WS (2020) Stealth coating of nanoparticles in drug-delivery systems. Nanomaterials (Basel) 10(4):787. https://doi.org/10.3390/nano1004078710.3390/nano10040787 ↗
37. Prasher P, Sharma M, Singh SP (2021) Drug encapsulating polysaccharide-loaded metal nanoparticles: a perspective drug delivery system. Drug Dev Res 82(2):145–148. https://doi.org/10.1002/ddr.2175410.1002/ddr.21754 ↗
38. Calvo P, Remunan-Lopez C, Vila-Jato JL, Alonso MJ (1997) Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J Appl Polym Sci 63(1):125–132. https://doi.org/10.1002/(SICI)1097-4628(19970103)63:1%3c125::AID-APP13%3e3.0.CO;2-410.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4 ↗
39. Morsi N, Ghorab D, Refai H, Teba HS (2015) Ketoroloac tromethamine loaded nanodispersion incorporated into thermosensitive in situ gel for prolonged ocular delivery. Int J Pharm Sci 7:234–240
40. Tan KW, Tang SY, Thomas R, Vasanthakumari N, Manickam S (2016) Curcumin-loaded sterically stabilized nanodispersion based on non-ionic colloidal system induced by ultrasound and solvent diffusion-evaporation. Pure Appl Chem 88(1–2):43–60. https://doi.org/10.1515/pac-2015-060110.1515/pac-2015-0601 ↗
41. Cui B, Wang C, Zhao X et al (2018) Characterization and evaluation of avermectin solid nanodispersion prepared by microprecipitation and lyophilisation techniques. PloS One 13(1):e0191742. https://doi.org/10.1371/journal.pone.019174210.1371/journal.pone.0191742 ↗
42. Nkansah P, Antipas A, Lu Y et al (2013) Development and evaluation of novel solid nanodispersion system for oral delivery of poorly water-soluble drugs. J Control Release 169(1–2):150–161. https://doi.org/10.1016/j.jconrel.2013.03.03210.1016/j.jconrel.2013.03.032 ↗
43. Wang R, Yang Y, Yang M et al (2020) J Nanobiotechnol 18:1–17. https://doi.org/10.1186/s12951-020-00679-210.1186/s12951-020-00679-2 ↗
44. Ribeiro HS, Chu BS, Ichikawa S, Nakajima M (2008) Preparation of nanodispersions containing β-carotene by solvent displacement method. Food Hydrocoll 22(1):12–17. https://doi.org/10.1016/j.foodhyd.2007.04.00910.1016/j.foodhyd.2007.04.009 ↗
45. Hiremath JG, Rajeshkumar A, Ickowicz D, Domb AJ (2013) Preparation and in vitro characterization of paclitaxel containing poly(lactic acid co-castor oil)-based nanodispersions. J Drug Deliv Sci Technol 23(5):439–444. https://doi.org/10.1016/S1773-2247(13)50063-310.1016/S1773-2247(13)50063-3 ↗
46. Kanaze FI, Kokkalou E, Niopas I, Barmpalexis P, Georgarakis E, Bikiaris D (2010) Dissolution rate and stability study of flavanone aglycones, naringenin and hesperetin, by drug delivery systems based on polyvinylpyrrolidone (PVP) nanodispersions. Drug Dev Ind Pharm 36(3):292–301. https://doi.org/10.1080/0363904090314058910.1080/03639040903140589 ↗
47. Bodas DS, Ige PP (2019) Central composite rotatable design for optimization of budesonide-loaded cross-linked chitosan-dextran sulfate nanodispersion: characterization, in vitro diffusion and aerodynamic study. Drug Dev Ind Pharm 45(7):1193–1204. https://doi.org/10.1080/03639045.2019.160682310.1080/03639045.2019.1606823 ↗
48. Martins M, Azoia NG, Shimanovich U et al (2014) Design of novel BSA/hyaluronic acid nanodispersions for transdermal pharma purposes. Mol Pharm 11(5):1479–1488. https://doi.org/10.1021/mp400657g10.1021/mp400657g ↗
49. Dudhipala N, Ali Youssef AAA, Banala N (2020) Colloidal lipid nanodispersion enriched hydrogel of antifungal agent for management of fungal infections: comparative in-vitro, ex-vivo and in-vivo evaluation for oral and topical application. Chem Phys Lipids 233:104981. https://doi.org/10.1016/j.chemphyslip.2020.10498110.1016/j.chemphyslip.2020.104981 ↗
50. Pourmorad F, Honari S, Ebrahimzadeh MA, Hosseinikhah F (2009) Nanodispersion of quercetin and ferulic acid. J Vac Sci Technol B 27(3):1583–1585. https://doi.org/10.1116/1.304951510.1116/1.3049515 ↗
51. Shikov AN, Pozharitskaya ON, Miroshnyk I et al (2009) Nanodispersions of taxifolin: impact of solid-state properties on dissolution behavior. Int J Pharm 377(1–2):148–152. https://doi.org/10.1016/j.ijpharm.2009.04.04410.1016/j.ijpharm.2009.04.044 ↗
52. Rossetti FC, Depieri LV, Praça FG et al (2016) Optimization of protoporphyrin IX skin delivery for topical photodynamic therapy: nanodispersions of liquid-crystalline phase as nanocarriers. Eur J Pharm Sci 83:99–108. https://doi.org/10.1016/j.ejps.2015.12.00310.1016/j.ejps.2015.12.003 ↗
53. Morsi N, Ghorab D, Refai H, Teba H (2016) Ketoroloac tromethamine loaded nanodispersion incorporated into thermosensitive in situ gel for prolonged ocular delivery. Int J Pharm 506(1–2):57–67. https://doi.org/10.1016/j.ijpharm.2016.04.02110.1016/j.ijpharm.2016.04.021 ↗
54. Tan CP, Nakajima M (2005) β-Carotene nanodispersions: preparation, characterization and stability evaluation. Food Chem 92(4):661–671. https://doi.org/10.1016/j.foodchem.2004.08.04410.1016/j.foodchem.2004.08.044 ↗
55. Chu BS, Ichikawa S, Kanafusa S, Nakajima M (2007) Preparation and characterization of beta-carotene nanodispersions prepared by solvent displacement technique. J Agric Food Chem 55(16):6754–6760. https://doi.org/10.1021/jf063609d10.1021/jf063609d ↗
56. Joshy KS, Augustine R, Li T et al (2020) Carboxymethylcellulose hybrid nanodispersions for edible coatings with potential anti-cancer properties. Int J Biol Macromol 157:350–358. https://doi.org/10.1016/j.ijbiomac.2020.04.17510.1016/j.ijbiomac.2020.04.175 ↗
57. Neto WS, Simões Dutra GV, de Sousa Brito Neta M et al (2021) Nanodispersions of magnetic poly(vinyl pivalate) for biomedical applications: synthesis and in vitro evaluation of its cytotoxicity in cancer cells. Mater Today Commun 27. https://doi.org/10.1016/j.mtcomm.2021.10233310.1016/j.mtcomm.2021.102333 ↗
58. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674. https://doi.org/10.1016/j.cell.2011.02.01310.1016/j.cell.2011.02.013 ↗
59. Baudino TA (2015) Targeted cancer therapy: the next generation of cancer treatment. Curr Drug Discov Technol 12(1):3–20. https://doi.org/10.2174/157016381266615060214431010.2174/1570163812666150602144310 ↗
60. Shen Z, Nieh MP, Li Y (2016) Decorating nanoparticle surface for targeted drug delivery: opportunities and challenges. Polymers 8(3):83. https://doi.org/10.3390/polym803008310.3390/polym8030083 ↗
61. Huang CL, Huang CC, Mai FD et al (2015) Application of paramagnetic graphene quantum dots as a platform for simultaneous dual-modality bioimaging and tumor-targeted drug delivery. J Mater Chem B 3(4):651–664. https://doi.org/10.1039/C4TB01650E10.1039/C4TB01650E ↗
62. Wani K, Tarawadi K, Kaul-Ghanekar R (2015) Nanocarriers for delivery of herbal based drugs in breast cancer – an overview. J Nano Res 34:29–40. https://doi.org/10.4028/www.scientific.net/JNanoR.34.2910.4028/www.scientific.net/JNanoR.34.29 ↗
63. Tian X, Bera H, Guo X et al (2021) Pulmonary delivery of reactive oxygen species/glutathione-responsive paclitaxel dimeric nanoparticles improved therapeutic indices against metastatic lung cancer. ACS Appl Mater Interfaces 13(48):56858–56872. https://doi.org/10.1021/acsami.1c1635110.1021/acsami.1c16351 ↗
64. Tan C, Hosseini SF, Jafari SM (2022) Cubosomes and hexosomes as novel nanocarriers for bioactive compounds. J Agric Food Chem 70(5):1423–1437. https://doi.org/10.1021/acs.jafc.1c0674710.1021/acs.jafc.1c06747 ↗
65. Athawale RB, Jain DS, Singh KK, Gude RP (2014) Etoposide loaded solid lipid nanoparticles for curtailing B16F10 melanoma colonization in lung. Biomed Pharmacother 68(2):231–240. https://doi.org/10.1016/j.biopha.2014.01.00410.1016/j.biopha.2014.01.004 ↗
66. Kothari IR, Mazumdar S, Sharma S, Italiya K, Mittal A, Chitkara D (2019) Docetaxel and alpha-lipoic acid co-loaded nanoparticles for cancer therapy. Ther Deliv 10(4):227–240. https://doi.org/10.4155/tde-2018-007410.4155/tde-2018-0074 ↗
67. Makeen HA, Mohan S, Al-Kasim MA et al (2020) Gefitinib loaded nanostructured lipid carriers: characterization, evaluation and anti-human colon cancer activity in vitro. Drug Deliv 27(1):622–631. https://doi.org/10.1080/10717544.2020.175452610.1080/10717544.2020.1754526 ↗
68. Uddin S, Islam MR, Chowdhury MR et al (2021) Lipid-based ionic-liquid-mediated nanodispersions as biocompatible carriers for the enhanced transdermal delivery of a peptide drug. ACS Appl Bio Mater 4(8):6256–6267. https://doi.org/10.1021/acsabm.1c0056310.1021/acsabm.1c00563 ↗
69. Theochari I, Mitsou E, Nikolic I et al (2021) Colloidal nanodispersions for the topical delivery of Ibuprofen: structure, dynamics and bioperformances. J Mol Liq 334:116021. https://doi.org/10.1016/j.molliq.2021.11602110.1016/j.molliq.2021.116021 ↗
70. Ipar VS, Dsouza A, Devarajan PV (2019) Enhancing curcumin oral bioavailability through nanoformulations. Eur J Drug Metab Pharmacokinet 44(4):459–480. https://doi.org/10.1007/s13318-019-00545-z10.1007/s13318-019-00545-z ↗
71. Mulik RS, Mönkkönen J, Juvonen RO, Mahadik KR, Paradkar AR (2010) Transferrin mediated solid lipid nanoparticles containing curcumin: enhanced in vitro anticancer activity by induction of apoptosis. Int J Pharm 398(1–2):190–203. https://doi.org/10.1016/j.ijpharm.2010.07.02110.1016/j.ijpharm.2010.07.021 ↗
72. Jain NK, Prabhuraj RS, Bavya MC et al (2019) Niclosamide encapsulated polymeric nanocarriers for targeted cancer therapy. RSC Adv 9(46):26572–26581. https://doi.org/10.1039/C9RA03407B10.1039/C9RA03407B ↗
73. Wang C, Cui B, Zhao X et al (2018) Optimization and characterization of lambda-cyhalothrin solid nanodispersion by self-dispersing method. Pest Manag Sci. https://doi.org/10.1002/ps.512210.1002/ps.5122 ↗
74. Elghani EMA, Omar FA, Emam MMAA et al (2022) Nat Prod Res 1–6. https://doi.org/10.1080/14786419.2022.210648410.1080/14786419.2022.2106484 ↗
75. Wakabayashi R, Sakuragi M, Kozaka S, Tahara Y, Kamiya N, Goto M (2018) Solid-in-oil peptide nanocarriers for transcutaneous cancer vaccine delivery against melanoma. Mol Pharm 15(3):955–961. https://doi.org/10.1021/acs.molpharmaceut.7b0089410.1021/acs.molpharmaceut.7b00894 ↗
76. Jain DS, Bajaj AN, Athawale RB et al (2016) Thermosensitive PLA based nanodispersion for targeting brain tumor via intranasal route. Mater Sci Eng C Mater Biol Appl 63:411–421. https://doi.org/10.1016/j.msec.2016.03.01510.1016/j.msec.2016.03.015 ↗
77. Elkholy NS, Hariri MLM, Mohammed HS, Shafaa MW (2023) Lutein and β-carotene characterization in free and nanodispersion forms in terms of antioxidant activity and cytotoxicity. J Pharm Innov. https://doi.org/10.1007/s12247-023-09745-210.1007/s12247-023-09745-2 ↗
78. Silva Garcia Praca F, Silva Garcia Medina W, Petrilli R, Bentley MVLB (2012) Liquid crystal nanodispersions enable the cutaneous delivery of photosensitizer for topical PDT: fluorescence microscopy study of skin penetration. Curr Nanosci 8(4):535–540. https://doi.org/10.2174/15734131280178420310.2174/157341312801784203 ↗
79. Khan S, Madni A, Shah H et al (2022) Folate decorated lipid chitosan hybrid nanoparticles of 5-fluorouracil for enhanced anticancer efficacy against colon cancer. Int J Biol Macromol 222(A):497–508. https://doi.org/10.1016/j.ijbiomac.2022.09.19610.1016/j.ijbiomac.2022.09.196 ↗
80. Rohilla S, Awasthi R, Mehta M et al (2022) Preparation and evaluation of gefitinib containing nanoliposomal formulation for lung cancer therapy. BioNanoSci 12(1):241–255. https://doi.org/10.1007/s12668-022-00938-610.1007/s12668-022-00938-6 ↗
81. Shamaeizadeh N, Varshosaz J, Mirian M, Aliomrani M (2022) Glutathione targeted tragacanthic acid-chitosan as a non-viral vector for brain delivery of miRNA-219a-5P: an in vitro/in vivo study. Int J Biol Macromol 200:543–556. https://doi.org/10.1016/j.ijbiomac.2022.01.10010.1016/j.ijbiomac.2022.01.100 ↗
82. Wang L, Li M, Zhang N (2012) Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapy. Int J Nanomedicine 7:3281–3294. https://doi.org/10.2147/IJN.S3252010.2147/IJN.S32520 ↗
83. Md S, Abdullah ST, Alhakamy NA et al (2021) Ambroxol hydrochloride loaded gastro-retentive nanosuspension gels potentiate anticancer activity in lung cancer (A549) cells. Gels 7(4):243. https://doi.org/10.3390/gels704024310.3390/gels7040243 ↗
84. Gao L, Liu G, Ma J et al (2014) Paclitaxel nanosuspension coated with P-gp inhibitory surfactants: II. Ability to reverse the drug-resistance of H460 human lung cancer cells. Colloids Surf B Biointerfaces 117:122–127. https://doi.org/10.1016/j.colsurfb.2014.02.01610.1016/j.colsurfb.2014.02.016 ↗
85. Xu J, Ma Y, Xie Y et al (2017) Design and evaluation of novel solid self-nanodispersion delivery system for andrographolide. AAPS PharmSciTech 18(5):1572–1584. https://doi.org/10.1208/s12249-016-0627-710.1208/s12249-016-0627-7 ↗
86. Qushawy M, Nasr A, Swidan S, Mortagi Y (2020) Development and characterization of glimepiride novel solid nanodispersion for improving its oral bioavailability. Sci Pharm 88(4):52. https://doi.org/10.3390/scipharm8804005210.3390/scipharm88040052 ↗
87. Rajalingam K, Krishnaswami V, Alagarsamy S, Kandasamy R (2021) Solubility enhancement of methotrexate by solid nanodispersion approach for the improved treatment of small cell lung carcinoma. Curr Top Med Chem 21(2):140–150. https://doi.org/10.2174/156802662099920090412024110.2174/1568026620999200904120241 ↗
88. Fardous J, Omoso Y, Yoshida K, Ono F, Patwary MKA, Ijima H (2022) Gel-in-water nanodispersion for potential application in intravenous delivery of anticancer drugs. J Biosci Bioeng 133(2):174–180. https://doi.org/10.1016/j.jbiosc.2021.10.00110.1016/j.jbiosc.2021.10.001 ↗
89. Trevizan LNF, Eloy JO, Luiz MT et al (2021) Anti-EGFR liquid crystalline nanodispersions for docetaxel delivery: Formulation, characterization and cytotoxicity in cancer cells. Colloids Surf A Physicochem Eng Asp 613:126058. https://doi.org/10.1016/j.colsurfa.2020.12605810.1016/j.colsurfa.2020.126058 ↗
90. Sayyar Z, Jafarizadeh-Malmiri H, Beheshtizadeh N (2022) A study on the anticancer and antimicrobial activity of Curcumin nanodispersion and synthesized ZnO nanoparticles. Process Biochem 121:18–25. https://doi.org/10.1016/j.procbio.2022.06.03310.1016/j.procbio.2022.06.033 ↗
91. Zhou Q, Hou K, Fu Z (2022) Transferrin-modified mangiferin-loaded SLNs: preparation, characterization, and application in A549 lung cancer cell. Drug Des Dev Ther 16:1767–1778. https://doi.org/10.2147/DDDT.S36653110.2147/DDDT.S366531 ↗
92. Patel VR, Agrawal YK (2011) Nanosuspension: an approach to enhance solubility of drugs. J Adv Pharm Technol Res 2(2):81–87. https://doi.org/10.4103/2231-4040.8295010.4103/2231-4040.82950 ↗
93. Jacob S, Nair AB, Shah J (2020) Emerging role of nanosuspensions in drug delivery systems. Biomater Res 24:3. https://doi.org/10.1186/s40824-020-0184-810.1186/s40824-020-0184-8 ↗
94. Wang L, Du J, Zhou Y, Wang Y (2017) Safety of nanosuspensions in drug delivery. Nanomedicine 13(2):455–469. https://doi.org/10.1016/j.nano.2016.08.00710.1016/j.nano.2016.08.007 ↗
95. Ao H, Li Y, Li H et al (2020) Preparation of hydroxy genkwanin nanosuspensions and their enhanced antitumor efficacy against breast cancer. Drug Deliv 27(1):816–824. https://doi.org/10.1080/10717544.2020.177037210.1080/10717544.2020.1770372 ↗
96. Liu Y, Wang R, Hou J et al (2018) Paclitaxel/chitosan nanosupensions provide enhanced intravesical bladder cancer therapy with sustained and prolonged delivery of paclitaxel. ACS Appl Bio Mater 1(6):1992–2001. https://doi.org/10.1021/acsabm.8b0050110.1021/acsabm.8b00501 ↗
97. Garg G, Saraf S, Saraf S (2007) Cubosomes: an overview. Biol Pharm Bull 30(2):350–353. https://doi.org/10.1248/bpb.30.35010.1248/bpb.30.350 ↗
98. Varghese R, Salvi S, Sood P, Kulkarni B, Kumar D (2022) Colloids Interface Sci Commun 46. https://doi.org/10.1016/j.colcom.2021.100561.10.1016/j.colcom.2021.100561 ↗
99. Sethuraman V, Janakiraman K, Krishnaswami V, Natesan S, Kandasamy R (2019) pH responsive delivery of lumefantrine with calcium phosphate nanoparticles loaded lipidic cubosomes for the site specific treatment of lung cancer. Chem Phys Lipids 224:104763. https://doi.org/10.1016/j.chemphyslip.2019.03.01610.1016/j.chemphyslip.2019.03.016 ↗
100. Janakiraman K, Krishnaswami V, Sethuraman V, Rajendran V, Kandasamy R (2019) Development of methotrexate-loaded cubosomes with improved skin permeation for the topical treatment of rheumatoid arthritis. Appl Nanosci 9(8):1781–1796. https://doi.org/10.1007/s13204-019-00976-910.1007/s13204-019-00976-9 ↗